SEC Form 4 · accession 0001209191-19-002289
Denali Therapeutics Inc. · DNLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carole Ho
Officer — Chief Medical Officer
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001714899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF4,F5 | Jan 2, 2019 | S | 4,875 | $19.43 | D | 143,515 | I | See footnote |
| Common StockF6,F5 | Jan 2, 2019 | S | 900 | $20.24 | D | 142,615 | I | See footnote |
| Common StockF7 | Jan 3, 2019 | M | 5,775 | $5.28 | A | 8,552 | D | |
| Common StockF8 | Jan 3, 2019 | S | 2,777 | $18.90 | D | 2,777 | D | |
| Common Stock | Jan 4, 2019 | M | 5,950 | $5.28 | A | 8,727 | D | |
| Common StockF9 | Jan 4, 2019 | S | 1,500 | $19.30 | D | 7,227 | D | |
| Common StockF10 | Jan 4, 2019 | S | 4,450 | $20.03 | D | 2,777 | D | |
| Common StockF1 | holding | — | — | — | 46,875 | D | ||
| Common StockF2 | holding | — | — | — | 25,000 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F11 | $5.28 | Jan 3, 2019 | M | 5,775 | D | — | Jul 1, 2026 | Common Stock | 5,775 | 108,335 | D |
| Stock Option (right to buy)F11 | $5.28 | Jan 4, 2019 | M | 5,950 | D | — | Jul 1, 2026 | Common Stock | 5,950 | 102,385 | D |
Explanation of responses
- F1The shares are held of record by Carole Ho and Rajat Rohatgi.
- F10The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.81 to $20.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F11Of the total 125,000 shares granted, 25% of the shares subject to the option vested on July 2, 2017 and an additional 1/48 of the shares vest monthly thereafter.
- F2The shares are held of record by the Rohatgi-Ho Irrevocable GST Trust, for which Reporting Person serves as trustee.
- F3The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
- F4The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $19.11 to $20.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F5The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
- F6The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.13 to $20.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F7Includes 1,894 shares acquired on May 31, 2018 and 883 shares acquired on November 30, 2018 under the Issuer's 2017 Employee Stock Purchase Plan.
- F8The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.56 to $19.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F9The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $18.77 to $19.76 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.